Home » Healthcare » Pharmaceuticals » Allergy Diagnostics And Treatment Market

Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) – Growth, Future Prospects, And Competitive Analysis, 2018 -2028

Name: Allergy Diagnostics And Treatment Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2023-10-10
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Allergy Diagnostics And Treatment Market

Summary
Table Of Content
Request Sample

Market Overview

The global market for allergy diagnostics and treatment is projected to experience substantial growth during the forecast period, driven by various influential factors. Factors such as increasing levels of environmental pollution worldwide and the growing penetration of healthcare insurance are expected to contribute to market growth. Moreover, the high prevalence of allergic diseases, which imposes a significant economic burden, along with increased investment by key players in allergy diagnostics, are propelling the expansion of the market. As of 2021, the global allergy diagnostics and treatment market was valued at USD 28.7 billion and is anticipated to achieve a compound annual growth rate (CAGR) of 6.7% from 2023 to 2028.

The growth of the market is supported by the rising prevalence of allergy disorders among children and the elderly, the growing adoption of in-vitro diagnostic (IVD) techniques, and improved accessibility to diagnostic tools in developing nations within the Asia-Pacific region. Allergies are immune responses triggered by allergens, which can be found in consumed food, inhaled particles, or substances that come into contact with the skin through injections or touch. Chronic allergic diseases rank fifth in the U.S. across all age groups, indicating an increase in allergic diseases over the past 50 years of global industrialization.

According to the World Allergy Organization (WAO), the prevalence of allergies ranges from 10% to 40% across all age groups, affecting over one billion people globally, and is projected to affect four billion by 2050. This leads to an escalating direct and indirect burden, manifested as rising healthcare costs, reduced productivity, and an adverse impact on quality of life. Consequently, the increasing prevalence of allergy disorders, combined with the introduction of innovative diagnostic and treatment solutions, is driving the growth of the allergy diagnostic and treatment market.

North America currently dominates the allergy diagnostic and treatment market, closely followed by Europe, mainly driven by the high prevalence of allergic diseases in the U.S. Research conducted by the Centers for Disease Control and Prevention in 2013 revealed that food allergies among children in the U.S. increased by approximately 50% between 1997 and 2011. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), over 17 million people in Europe were affected by food allergies in 2015.

Key market trends and drivers:

Factors such as evolving lifestyles, increasing pollution, hazardous practices like smoking, and urbanization contribute to the rising prevalence of allergic conditions. The introduction of therapeutically advanced drugs like immunotherapy, which address unmet patient needs, is projected to drive market growth during the forecast period. The high incidence of allergies is one of the primary drivers of the expansion of the allergy therapeutics market. Increased exposure to indoor and outdoor air pollutants, as well as occupational exposure, are key risk factors for chronic respiratory diseases. Allergy prevalence is significantly higher in urban populations compared to rural areas due to increased exposure to environmental pollutants resulting from industrial activities and urbanization.

Moreover, the substantial prevalence of lifestyle-related disorders, including obesity, diabetes, and hypertension, is anticipated to have a significant impact on the allergic population. These conditions have the potential to alter an individual’s immune response to allergens and increase their susceptibility to allergies. Consequently, there has been an increasing emphasis on early identification and treatment of allergies, aiming to enhance patient outcomes and mitigate the economic burden associated with allergic diseases. The emergence of advanced diagnostic technologies, such as molecular diagnostics and biomarkers, has further propelled the growth of the allergy diagnostics market.

According to the Mayo Clinic, approximately 8% of children under five and up to 4% of adults are affected by food allergies. Furthermore, the Asthma and Allergy Foundation of America reported that in 2021, around 81 million people in the U.S. were diagnosed with seasonal allergic rhinitis, accounting for about 26% of adults and 19% of children affected. The development of cost-effective and efficient in vitro diagnostic tests for allergy determination, along with growing lab automation and an increase in reagent rental agreements, are expected to contribute to the growth of the allergy diagnostics and therapeutics market in the coming years. Studies involving biosensors combined with nanoparticles for detecting allergenic compounds are currently underway, with gold nanoparticles being primarily used due to their ease of synthesis.

Manufacturers are now focusing on restructuring their drug development processes to meet the global needs of patients. For example, in September 2020, Dr. Reddy’s announced the launch of its OTC eye allergy drop called Olopatadine Hydrochloride Ophthalmic Solution. The side effects associated with conventional therapies, such as drowsiness, blurred vision, insomnia, and loss of appetite, are driving the need to develop a new generation of drugs. The substantial research and development investment being made by these companies is expected to facilitate the large-scale development of new drug candidates. For instance, in November 2021, Angany and Lincoln Diagnostics collaborated on Angany’s approach to allergists in the U.S. Angany presents an innovative approach to allergy immunotherapy based on integrative science, aiming to overcome the limitations of current desensitization methods.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Key market challenges

Despite the promising growth prospects, the allergy diagnostic and therapeutics market faces significant challenges that could impede its expansion. One of the primary barriers is the high cost of allergy diagnostic tests and treatments, which may discourage individuals from seeking necessary medical attention. Furthermore, the lack of awareness regarding the severity of allergies, combined with symptoms being misdiagnosed, often leads to delayed, appropriate intervention, thus exacerbating health risks. Additionally, stringent regulations and the lengthy approval process for new diagnostic technologies and therapeutic drugs could hinder market growth. Lastly, certain treatments’ side effects, including drowsiness, blurred vision, insomnia, and loss of appetite, pose another notable challenge. Therefore, there is an increasing demand for innovative, cost-effective, and accurate diagnostic and treatment solutions with minimal adverse effects.

Competitive Analysis

The allergy diagnostics and therapeutics market is replete with key market players that are continuously contributing to its growth.

These leading entities include:

ACON Laboratories, Inc.

AESKU.GROUP GmbH

Astra Biotech GmbH

bioMérieux SA

Danaher

Erba Group

Eurofins Scientific

EUROIMMUN Medizinische Labordiagnostika AG

HOB Biotech Group Corp., Ltd.

HollisterStier Allergy

HYCOR Biomedical

Lincoln Diagnostics, Inc.

Minaris Medical America, Inc.

NEOGEN Corporation

Omega Diagnostics Group PLC

R-Biopharm AG

Romer Labs Division Holding

Siemens Healthineers

Stallergenes Greer

Thermo Fisher Scientific, Inc.

Recent Developments and News:

In November 2019, significant advancements were noted in the sphere of allergy research and potential treatments, with a particular emphasis on augmenting the growth of the related market. Conducted by the Center for Allergy and Asthma Research at Stanford University and facilitated by funding from AnaptysBio, Inc., research unveiled that a solitary dose of etokimab may have the potential to desensitize peanut-allergic participants, in addition to potentially diminishing atopy-related adverse events.
In April 2019, HypoPet announced the release of crucial preclinical data pertaining to their cat allergy vaccine, HypoCatTM. The disclosed data demonstrated that HypoPet’s vaccine, employing virus-like particle technology to target Fel d1, the principal feline allergen affecting humans, was able to successfully induce the formation of binding antibodies within cats. Moreover, these antibodies effectively neutralized the allergen, showcasing a notable stride in addressing feline-related allergic reactions in humans.
In October 2019, a study was published in the Australasian Journal of Dermatology, revealing that fragrances have been identified as the leading catalyst of allergic skin reactions in children. This insight underscores the imperative for continued, meticulous research into diverse allergens and their resultant management and treatment strategies, thereby accentuating the potential for further innovative breakthroughs in the allergy research domain.

Segmentations Analysis

Based on the type of products, the global allergy diagnostics market is segmented as follows:

Assay Kits
Consumables
Instruments

Among the product types, consumables dominate the global allergy diagnostics and treatment market, and it is also the fastest-growing market, followed by assay kits and instruments. Consumables are required on a large scale, so high volume and low cost play an important role in occupying a greater share of the global allergy diagnostics and treatment market. The current assays are simple to use and handle, with high-precision results. These diagnostic kits are more time-saving and show enhanced sensitivity.

Based on the type of tests, the global allergy diagnostics market is segmented as follows:

In vivo tests
In vitro tests

In 2016, in vivo tests dominated the global allergy diagnostics market. In vivo testing is faster, more sensitive, and less expensive than in vitro testing, so it is preferred. Currently, skin tests are the best available option for the detection of allergen-specific IgE. The adoption of skin tests among healthcare professionals and patients is high. In vitro tests are carried out in certain circumstances, such as if the skin is abnormal or a history of sensitivity is observed in the patient. While rising demand for less invasive diagnostics drives laboratory technological advancement, the in vitro testing segment is expanding.

Based on the type of treatment, the global allergy treatment market is segmented as follows:

Antihistamines
Autoinjectable Epinephrine
Corticosteroids
Decongestants
Immunomodulators
Immunotherapy
Leukotriene Inhibitors
Mast cell stabilizers
Nasal Anticholinergics

In 2016, antihistamines were the most commonly used treatment for allergic diseases, thus dominating the global allergy treatment market. Corticosteroids, which are highly effective allergy medications, are the next to hit the market. Immunotherapy is expected to be the fastest-growing segment in the allergy treatment market. Immunotherapy is showing fast adoption as it is cost-effective, decreases sensitivity to allergens, and provides long-lasting relief from allergy symptoms.

Based on the type of allergen, the global allergy diagnostics and treatment market is segmented as follows:

Food Allergens
Inhaled Allergens
Drug Allergens
Other

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

The rising incidence of inhaled allergies and asthma due to growing pollution and urbanization contributes to the growth of the allergy diagnostics and treatment market. Thus, inhaled allergens occupy the largest revenue share for the year 2016. Allergic rhinitis affects almost 10%–30% of the adult population and 40% of children. Global warming and changes in pollination seasons are some of the major reasons for the growing incidence of asthma and allergic rhinitis. Food allergies are more commonly observed in children than in adults. Drug allergens are anticipated to be the fastest-growing segment during the forecast period of 2018–2028.

For the purpose of this study, the global allergy diagnostic and treatment market is geographically categorized into:

North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
rest of Latin America
Middle East and Africa
UAE
Saudi Arabia
South Africa
Rest of the Middle East and Africa

At present, North America occupies the largest share of the global allergy diagnostic and treatment market, followed by Europe. The rising incidence of allergic diseases, particularly those related to respiratory function, increasing awareness of allergy diagnostics, a well-supported healthcare structure, favorable reimbursement policies, and enhanced diagnostic technology are some of the major driving factors for the allergy diagnostics and treatment market. Around 150 million Europeans suffer from chronic allergic diseases, which are predicted to cover almost half the population of Europe by 2026 One of the key factors driving the allergy diagnostics and treatment market is an increase in the geriatric population. Asia Pacific is anticipated to be the fastest-growing allergy diagnostics and treatment market in the forecast period. The rising prevalence of allergic diseases and asthma, particularly in developing countries, poses a major threat to health and economies. Thus, high unmet needs, improved healthcare infrastructure, rising pollution, and increasing disposable income are some of the factors governing the demand for allergy diagnostics and treatment in the Asia-Pacific region.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Allergy Diagnostics and Treatment Market Portraiture
2.1.1. Global Allergy Diagnostics and Treatment Market, by Product Type,
2.1.2. Global Allergy Diagnostics and Treatment Market, by Allergen Type,
2.1.3. Global Allergy Diagnostics and Treatment Market, by Test Type,
2.1.4. Global Allergy Diagnostics and Treatment Market, by Treatment Type,
2.1.5. Global Allergy Diagnostics and Treatment Market, by Geography,

Chapter 3. Allergy Diagnostics and Treatment Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players,

Chapter 4. Global Allergy Diagnostics Market, by Product Type, (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Allergy Diagnostics Market, by Product Type
4.3. Assay Kits
4.4. Consumables
4.5. Services

Chapter 5. Global Allergy Diagnostics Market, by Test Type, (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Allergy Diagnostics Market, by Test Type
5.3. In vivo tests
5.4. In vitro tests

Chapter 6. Global Allergy Treatment Market, by Treatment Type, (US$ Mn)
6.1. Overview
6.2. Attractive Investment Proposition: Global Allergy Treatment Market, by Treatment Type
6.3. Antihistamines
6.4. Autoinjectable Epinephrine
6.5. Corticosteroids
6.6. Decongestants
6.7. Immunomodulators
6.8. Immunotherapy
6.9. Leukotriene Inhibitors
6.10. Mast Cell Stabilizers
6.11. Nasal Anticholinergics

Chapter 7. Global Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
7.1. Overview
7.2. Attractive Investment Proposition: Global Allergy Diagnostics and Treatment Market, by Allergen Type
7.3. Food Allergen
7.4. Inhaled Allergen
7.5. Drug Allergen
7.6. Other Allergen

Chapter 8. Global Allergy Diagnostics and Treatment Market, by Geography, (US$ Mn)
8.1. Overview
8.2. North America Allergy Diagnostics and Treatment Market Analysis,
8.2.1. North America Allergy Diagnostics Market, by Product Type, (US$ Mn)
8.2.2. North America Allergy Diagnostics Market, by Test Type, (US$ Mn)
8.2.3. North America Allergy Treatment Market, by Treatment Type, (US$ Mn)
8.2.4. North America Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
8.2.5. North America Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
8.2.5.1. U.S.
8.2.5.2. Canada
8.3. Europe Allergy Diagnostics and Treatment Market Analysis,
8.3.1. Europe Allergy Diagnostics Market, by Product Type, (US$ Mn)
8.3.2. Europe Allergy Diagnostics Market, by Test Type, (US$ Mn)
8.3.3. Europe Allergy Treatment Market, by Treatment Type, (US$ Mn)
8.3.4. Europe Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
8.3.5. Europe Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
8.3.5.1. U.K.
8.3.5.2. Germany
8.3.5.3. France
8.3.5.4. Rest of Europe
8.4. Asia Pacific Allergy Diagnostics and Treatment Market Analysis,
8.4.1. Asia Pacific Allergy Diagnostics Market, by Product Type, (US$ Mn)
8.4.2. Asia Pacific Allergy Diagnostics Market, by Test Type, (US$ Mn)
8.4.3. Asia Pacific Allergy Treatment Market, by Treatment Type, (US$ Mn)
8.4.4. Asia Pacific Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
8.4.5. Asia Pacific Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
8.4.5.1. Japan
8.4.5.2. China
8.4.5.3. India
8.4.5.4. Rest of APAC
8.5. Latin America Allergy Diagnostics and Treatment Market Analysis,
8.5.1. Latin America Allergy Diagnostics Market, by Product Type, (US$ Mn)
8.5.2. Latin America Allergy Diagnostics Market, by Test Type, (US$ Mn)
8.5.3. Latin America Allergy Treatment Market, by Treatment Type, (US$ Mn)

8.5.4. Latin America Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
8.5.5. Latin America Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
8.5.5.1. Brazil
8.5.5.2. Mexico
8.5.5.3. Rest of Latin America
8.6. Middle East & Africa (MEA) Allergy Diagnostics and Treatment Market Analysis,
8.6.1. MEA Allergy Diagnostics Market, by Product Type, (US$ Mn)
8.6.2. MEA Allergy Diagnostics Market, by Test Type, (US$ Mn)
8.6.3. MEA Allergy Treatment Market, by Treatment Type, (US$ Mn)
8.6.4. MEA Allergy Diagnostics and Treatment Market, by Allergen, (US$ Mn)
8.6.5. MEA Allergy Diagnostics and Treatment Market, by Region, (US$ Mn)
8.6.5.1. UAE
8.6.5.2. Saudi Arabia
8.6.5.3. South Africa
8.6.5.4. Rest of MEA

Chapter 9. Company Profiles
9.1. Alcon Laboratories, Inc.
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Product Portfolio
9.1.4. Key Developments
9.2. BioMerieux, Inc
9.3. Danaher Corporation
9.4. Hitachi Chemical Diagnostics, Inc
9.5. HOB Biotech Group Co.,Ltd.
9.6. Hycor Biomedical, Inc.
9.7. Lincoln Diagnostics, Inc.
9.8. Omega Diagnostics Plc.
9.9. Siemens Healthcare Diagnostic, Inc.
9.10. Stallergenes Greer, Inc.
9.11. Thermo Fisher Scientific, Inc.
9.12. Other Notable Players

List of Figures

FIG. 1 Allergy Diagnostics and Treatment: Market Segmentation
FIG. 2 Global Allergy Diagnostics Market Share, by Product Type, (US$ Mn)
FIG. 3 Global Allergy Diagnostics and Treatment Market Share, by Allergen Type, (US$ Mn)
FIG. 4 Global Allergy Diagnostics Market Share, by Test Type, (US$ Mn)
FIG. 5 Global Allergy Treatment Market, by Treatment Type, (US$ Mn)
FIG. 6 Global Allergy Diagnostics and Treatment Market, by Geography, (Value %)
FIG. 7 Attractive Investment Proposition, by Geography
FIG. 8 Market Competition Landscape, by Key Players,
FIG. 9 Global Allergy Diagnostics Instruments Market, (US$ Mn)
FIG. 10 Global Allergy Diagnostics Consumables Market, (US$ Mn)
FIG. 11 Global Allergy Diagnostics Assay Kits Market, (US$ Mn)
FIG. 12 Global Allergy Diagnostics and Treatment Food Allergen Market, (US$ Mn)
FIG. 13 Global Allergy Diagnostics and Treatment Inhaled Allergen Market, (US$ Mn)
FIG. 14 Global Allergy Diagnostics and Treatment Drug Allergen Market, (US$ Mn)
FIG. 15 Global Allergy Diagnostics and Treatment Others Market, (US$ Mn)
FIG. 16 Global Allergy Diagnostics In-vivo Test Market, (US$ Mn)
FIG. 17 Global Allergy Diagnostics In vitro Test Market, (US$ Mn)
FIG. 18 Global Allergy Treatment Antihistamines Market, (US$ Mn)
FIG. 19 Global Allergy Treatment Autoinjectable Epinephrine Market, (US$ Mn)
FIG. 20 Global Allergy Treatment Corticosteroids Market, (US$ Mn)
FIG. 21 Global Allergy Treatment Decongestants Market, (US$ Mn)
FIG. 22 Global Allergy Treatment Immunomodulators Market, (US$ Mn)
FIG. 23 Global Allergy Treatment Immunotherapy Market, (US$ Mn)
FIG. 24 Global Allergy Treatment Leukotriene Inhibitors Market, (US$ Mn)
FIG. 25 Global Allergy Treatment Mast Cell Stabilizers Market, (US$ Mn)
FIG. 26 Global Allergy Treatment Nasal Anticholinergics Market, (US$ Mn)
FIG. 27 U.S. Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 28 Canada Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 29 U.K. Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 30 Germany Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 31 France Allergy Diagnostics and Treatment Market, 2015-2025 (US$ Mn)
FIG. 32 Rest of Europe Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 33 Japan Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 34 China Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 35 India Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 36 Rest of Asia Pacific Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 37 Brazil Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 38 Mexico Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 39 Rest of Latin America Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 40 UAE Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 41 Saudi Arabia Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 42 South Africa Allergy Diagnostics and Treatment Market, (US$ Mn)
FIG. 43 Rest of Middle East and Africa Allergy Diagnostics and Treatment Market, (US$ Mn)

List of Tables

TABLE 1 Global Allergy Diagnostics Market, by Product Type, (US$ Mn)
TABLE 2 Global Allergy Diagnostics Market, by Test Type, (US$ Mn)
TABLE 3 Global Allergy Treatment Market, by Treatment Type,
(US$ Mn)
TABLE 4 Global Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
TABLE 5 North America Allergy Diagnostics Market, by Product Type, (US$ Mn)
TABLE 6 North America Allergy Diagnostics Market, by Test Type, (US$ Mn)
TABLE 7 North America Allergy Treatment Market, by Treatment Type, (US$ Mn)
TABLE 8 North America Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
TABLE 9 North America Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
TABLE 10 Europe Allergy Diagnostics Market, by Product Type, (US$ Mn)
TABLE 11 Europe Allergy Diagnostics Market, by Test Type, (US$ Mn)
TABLE 12 Europe Allergy Treatment Market, by Treatment Type, (US$ Mn)
TABLE 13 Europe Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
TABLE 14 Europe Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
TABLE 15 Asia Pacific Allergy Diagnostics Market, by Product Type, (US$ Mn)
TABLE 16 Asia Pacific Allergy Diagnostics Market, by Test Type, (US$ Mn)
TABLE 17 Asia Pacific Allergy Treatment Market, by Treatment Type, (US$ Mn)
TABLE 18 Asia Pacific Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
TABLE 19 Asia Pacific Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
TABLE 20 Latin America Allergy Diagnostics Market, by Product Type, (US$ Mn)
TABLE 21 Latin America Allergy Diagnostics Market, by Test Type, (US$ Mn)
TABLE 22 Latin America Allergy Treatment Market, by Treatment Type, (US$ Mn)
TABLE 23 Latin America Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
TABLE 24 Latin America Allergy Diagnostics and Treatment Market, by Country, (US$ Mn)
TABLE 25 Middle East and Africa Allergy Diagnostics Market, by Product Type, (US$ Mn)
TABLE 26 Middle East and Africa Allergy Diagnostics Market, by Test Type, (US$ Mn)
TABLE 27 Middle East and Africa Allergy Treatment Market, by Treatment Type, (US$ Mn)
TABLE 28 Middle East and Africa Allergy Diagnostics and Treatment Market, by Allergen Type, (US$ Mn)
TABLE 29 Middle East and Africa Allergy Diagnostics and Treatment Market, by Region, (US$ Mn)
TABLE 30 Alcon Laboratories, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 31 BioMerieux, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 32 Danaher Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 33 Hitachi Chemical Diagnostics,Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 34 HOB Biotech Group Co.,Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 35 Hycor Biomedical, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 36 Lincoln Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 37 Omega Diagnostics Plc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 38 Siemens Healthcare Diagnostic, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 39 Stallergenes Greer, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 40 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

What are some factors contributing to the growth of the allergy diagnostics and therapeutics market?

The prevalence of lifestyle-related disorders such as obesity, diabetes, and hypertension, which may alter an individual’s immune response to allergens, is one factor. Additionally, advancements in diagnostic technologies like molecular diagnostics and biomarkers, development of cost-effective in vitro diagnostic tests, and growing lab automation have all contributed to the market growth.

How are manufacturers restructuring their drug development processes?

Manufacturers are restructuring their drug development processes to meet global patient needs. These changes include the launch of new products like Dr. Reddy’s OTC eye allergy drop, Olopatadine Hydrochloride Ophthalmic Solution, and collaborative efforts like the one between Angany and Lincoln Diagnostics to improve allergy immunotherapy.

What challenges does the allergy diagnostic and therapeutics market face?

The market faces challenges like the high cost of diagnostic tests and treatments, lack of awareness about the severity of allergies, misdiagnosis, and stringent regulations for approval of new diagnostic technologies and therapeutic drugs. Side effects from certain treatments also pose challenges.

What are some recent advancements in allergy-related research and development?

Notable advancements include a study by Stanford University’s Center for Allergy and Asthma Research indicating the potential of etokimab to desensitize individuals allergic to peanuts. HypoPet also announced the publication of crucial preclinical data for their cat allergy vaccine, HypoCat™, which targets the primary allergen.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Food Allergy Treatment Market

The Food Allergy Treatment Market is projected to grow from USD 6,250 million in 2024 to USD 13,175 million by 2032, with a compound annual growth rate (CAGR) of 9.77% during the forecast period.

Allergy Diagnostics Market

The Allergy Diagnostics Market is projected to grow from USD 6,215 million in 2024 to USD 11,100.82 million by 2032, reflecting a compound annual growth rate (CAGR) of 7.52%.

OTC Cough Cold And Allergy Medicine Market

The Over-The-Counter (OTC) cough, cold, and allergy medicine market experienced substantial growth from USD 38,955.23 million in 2023 to USD 66,535 million by 2032, representing a CAGR of 5.16%

Allergy Immunotherapy Market

As per the report by Credence Research, the market stood at a net value of approx. $1.19 billion in 2020 and is expected to grow at a CAGR of around 10.7% between 2021 and 2028.

Montelukast Sodium Market

The montelukast sodium market was valued at USD 519.8 million in 2024 and is projected to reach USD 1,623.6 million by 2032, expanding at a compound annual growth rate (CAGR) of 15.3% from 2024 to 2032.

Eosinophilic Esophagitis Market

The Eosinophilic Esophagitis (EoE) market size was valued at USD 1302.4 million in 2024 and is anticipated to reach USD 6300.2 million by 2032, growing at a compound annual growth rate (CAGR) of 21.78% during the forecast period.

Antigen Skin Market

The antigen skin test market is projected to grow from USD 6,898 million in 2024 to USD 11,502 million by 2032, registering a CAGR of 6.6% during the forecast period.

Hypoallergenic Infant Formula For CMPA Market

The Global Hypoallergenic Infant Formula For CMPA Market is projected to grow from USD 4,370.0 million in 2024 to an estimated USD 9,518.7 million based on 2032, with a compound annual growth rate (CAGR) of 8.60% from 2025 to 2032.

Dairy Free Cream Liqueur Market

The Dairy Free Cream Liqueur Market is projected to grow from USD 2,035.38 million in 2024 to USD 4,459.12 million by 2032, at a CAGR of 10.3%.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample